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A B S T R A C T
Bacillus anthracis, the etiological agent of anthrax, manifests a particular bimodal lifestyle. This bacterial
species alternates between short replication phases of 20–40 generations that strictly require infection
of the host, normally causing death, interrupted by relatively long, mostly dormant phases as spores in
the environment. Hence, the B. anthracis genome is highly homogeneous. This feature and the fact that
strains from nearly all parts of the world have been analysed for canonical single nucleotide
polymorphisms (canSNPs) and variable number tandem repeats (VNTRs) has allowed the development
of molecular epidemiological and molecular clock models to estimate the age of major diversiﬁcations in
the evolution of B. anthracis and to trace the global spread of this pathogen, which was mostly promoted
by movement of domestic cattle with settlers and by international trade of contaminated animal
products. From a taxonomic and phylogenetic point of view, B. anthracis is a member of the Bacillus cereus
group. The differentiation of B. anthracis from B. cereus sensu stricto, solely based on chromosomal
markers, is difﬁcult. However, differences in pathogenicity clearly differentiate B. anthracis from B. cereus
and are marked by the strict presence of virulence genes located on the two virulence plasmids pXO1 and
pXO2, which both are required by the bacterium to cause anthrax. Conversely, anthrax-like symptoms
can also be caused by organisms with chromosomal features that are more closely related to B. cereus,
but which carry these virulence genes on two plasmids that largely resemble the B. anthracis virulence
plasmids.
 2011 Elsevier B.V. 
Contents lists available at ScienceDirect
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Bacillus anthracis, the causative agent of anthrax, is a sporulat-
ing Gram-positive bacterium. Anthrax primarily affects ruminants,
although other mammals may also succumb to the disease but less* Corresponding author. Tel.: +41 31 631 2430; fax: +41 31 631 2634.
E-mail address: joachim.frey@vetsuisse.unibe.ch (J. Frey).
1567-1348       2011 Elsevier B.V. 
doi:10.1016/j.meegid.2011.05.013
Open access under CC BY-NC-ND license.frequently. Humans generally acquire anthrax from infected
animals or as the result of occupational or nutritional exposure
to contaminated animal products. The disease is endemic
worldwide but occurs only sporadically in countries where drastic
eradication measures have been established and implemented
(WHO, 1998). The potential use of B. anthracis spores as a
bioterrorism and warfare agent has strongly promoted research on
the molecular mechanisms of virulence, forensic methods to trace
the origin of speciﬁc strains and phylogenetic lineages of B.
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Ert et al., 2007a; Koehler, 2009; van der Goot and Young, 2009).
An important biological feature of B. anthracis is the alternation
between the vegetative phase and the spore phase. This bacterium
is principally found in the environment as a spore, where it is
metabolically dormant and does not replicate. However, it has
been observed that B. anthracis can grow vegetatively in
autoclaved, rich soil after being cured of one of the virulence
plasmids pXO2. This indicates that certain virulence attributes not
only are advantageous for B. anthracis to infect and multiply in the
host, but also confer host restriction (Saile and Koehler, 2006).
Generally, B. anthracis solely replicates during short periods of
infection, which are terminated by host death or by clearance of
the bacteria by the immune system or therapeutic agents. Genetic
evolution of B. anthracis is therefore limited to the short vegetative
periods from infection to host death, which is estimated to cover
20–40 generations (Keim et al., 2004). Due to the long dormant
spore periods, this pathogen evolves very slowly, in contrast to
most other bacteria with similar generation times. For this reason,
B. anthracis is genetically and phenotypically extremely homoge-
neous. Conventional methods such as serology, biochemical tests
and phage typing are not appropriate to differentiate among
strains (WHO, 1998). The advent of rapid sequencing methods has
resulted in the availability of several complete B. anthracis genome
sequences (Pearson et al., 2004). These data allowed the
identiﬁcation, by genome comparison, of several genetic markers
for discrimination of strains and the study of population genetics of
this bacterium over long time periods (Keim et al., 2009).
This review will give a summary of more recent knowledge
acquired via these new molecular methods into the molecular
taxonomy, population genetics, phylogeny and patho-evolution of
B. anthracis.
2. Taxonomy
Bacterial taxonomy includes both phenotypic and genotypic
characteristics and leads to the biological binomial nomenclature
based on the genus (generic name) followed by the species (speciﬁc
name) (Woese, 1994; Prescott et al., 1999; Moore et al., 2010). B.
anthracis belongs to the phylum Firmicutes, the family Bacillaceae,
the genus Bacillus and the Bacillus cereus group. The latter consists
of six members: B. anthracis, B. cereus, B. mycoides, B. pseudomy-
coides, B. thuringiensis and B. weihenstephanensis. These species are
closely related and have been traditionally separated into different
species based on phenotypic characteristics, pathogenicity, clinical
symptoms, host preference and ecological niche (Rasko et al.,
2005). Most of these bacteria are of economic, environmental,
medical and biodefence importance. While the main pathogenic
characteristics of this group of bacteria can be attributed to toxins
that are generally encoded on plasmids, the chromosomes of the
different members of the B. cereus group show a high level of
synteny and protein similarity with little difference in gene
content (Ko et al., 2004; Rasko et al., 2005). The identiﬁcation of
individual species of the B. cereus group is therefore complex, and
some isolates display unusual biochemical and/or physiological
properties that complicate their accurate distinction (Klee et al.,
2006; Ross et al., 2009; Beesley et al., 2010). Phylogenetically, the B.
cereus group of bacteria is divided into 3 distinct clades (Priest
et al., 2004; Ko et al., 2004; Helgason et al., 2004; Didelot et al.,
2009) that show partial barriers to interclade gene ﬂow (Didelot
et al., 2009). Most pathogenic B. cereus strains are evenly
distributed among clades 1 and 2. The insect pathogen B.
thuringiensis is primarily found in clade 2. Clade 3 contains B.
cereus, B. mycoides and B. weihenstephanensis (Helgason et al., 2000,
2004; Priest et al., 2004; Sorokin et al., 2006; Didelot et al., 2009).
Strains of B. anthracis, in contrast to the other species, are strictlyclonal and are restricted to clade 1 along with the highly virulent
emetic toxin-producing B. cereus (Didelot et al., 2009).
B. anthracis can be identiﬁed using a battery of speciﬁc
bacteriological tests that examine colony morphology, capsule
staining, lack of hemolysis, sensitivity to g-phage, sensitivity to
penicillin and motility (WHO, 1998). Nevertheless, some strains
may show variability in terms of phenotype, complicating the
exact identiﬁcation and differentiation between B. anthracis and
other types of B. cereus, although these two species show entirely
different pathological manifestations (Klee et al., 2006; Ross et al.,
2009; Beesley et al., 2010). B. anthracis, a severe zoonotic pathogen
of ruminants, causes life threatening anthrax. Nonetheless, strains
with characteristics of B. cereus have been isolated from animals
with clinical anthrax (P. Pilo, unpublished; Klee et al., 2006). Hence,
several established genetic markers for B. anthracis, such as the
chromosomal locus Ba813 (Patra et al., 1996) or the gene sap
encoding the S-layer protein (Ryu et al., 2003), can result in
ambiguous diagnostic identiﬁcation of B. anthracis (Ramisse et al.,
1999).
The key virulence determinants that differentiate pathogenic
species of the B. cereus group in their pathogenicity and host
speciﬁcity represent relatively small portions of their genomes.
These genome segments are harboured by mobile elements and
were likely acquired by gene transfer from other species rather
than evolved by adaptation in their respective hosts. In B. anthracis,
virulence is determined by two plasmids named pXO1 (toxin
plasmid) and pXO2 (capsule plasmid) (Fig. 1), which under certain
circumstances are capable of being transferred between related
species, particularly among B. cereus clade 1 (Ruhfel et al., 1984;
Pannucci et al., 2002a; Hoffmaster et al., 2004; Klee et al., 2006;
Didelot et al., 2009; Hu et al., 2009).
3. Molecular mechanisms of pathogenicity and host–pathogen
interactions
The key virulence factors in B. anthracis are encoded on the two
virulence plasmids pXO1 (182 kb) and pXO2 (96 kb) (Mikesell
et al., 1983; Uchida et al., 1985). Plasmid pXO1 encodes two binary
toxins: lethal factor (LF), a zinc metalloprotease, and oedema factor
(EF), a calmodulin-dependent adenylate-cyclase. These toxins
share the same adhesion subunit, known as protective antigen
(PA), that binds to the cellular receptors tumour endothelial
marker 8 (TEM8) and capillary morphogenesis protein 2 (CMG2)
(Bradley et al., 2001). After binding, PA is cleaved by furin and
oligomerizes and binds LF or EF for transport into cells via
membrane lipid rafts (Abrami et al., 2003) (Fig. 1). Once inside the
cell, LF exerts its toxic activity by cleavage of the N-terminal
portion of mitogen-activated protein kinase kinase (MAPKK)
causing cell lysis or induction of pro-inﬂammatory cytokines
leading to vascular collapse, shock and death (Moayeri et al., 2003)
(Fig. 1). In the host cell, EF catalyses the conversion of ATP to cAMP,
deregulating a broad spectrum of cytokine responses in the host
(Tang and Guo, 2009) (Fig. 1). During early infection and
germination, when doses are sub-lethal, LT and EF seem to
suppress the cellular immune and cytokine responses allowing
bacterial outgrowth and dispersion throughout the host body
(Moayeri and Leppla, 2004).
The plasmid pXO2 encodes the enzymes that synthesize the
poly-D-glutamic acid capsule. This virulence factor is necessary for
survival in macrophages, which is a crucial step in the course of
disease. The poly-D-glutamic acid capsule and the two anthrax
toxins are the key phenotypes distinguishing B. anthracis from
closely related species. The presence of the two plasmids pXO1 and
pXO2 carrying the capsular biosynthesis genes capBCADE is
currently the crucial diagnostic evidence to conﬁrm infection
with B. anthracis (WHO, 1998). The loss of one or both of these
Fig. 1. Overview of the molecular mechanisms of virulence of Bacillus anthracis. B. anthracis (upper left) synthesizes the 4 major virulence factors: the lethal toxin zinc
metalloprotease (LF), the oedema factor calmodulin-dependent adenylate cyclase (EF) and the protective antigen (PA), which is the adhesive subunit of the two toxins, all of
which are encoded on plasmid pXO1, and the poly-D-glutamic acid polymer capsule (CAP) that allows survival of the bacterium in macrophages and is encoded on plasmid
pXO2. PA binds to the receptors on the host cell, TEM8 and CMG2 (see text), and is subsequently cleaved by furin, allowing multimerization and binding of LF or EF. The PA:EF
and PA:LF complexes are then internalized by endocytosis. In the acid environment of the endosomes, the PA:EF and PA:LF complexes are dissolved and exert their toxic
activities by inhibiting oxidative burst through cAMP or release of pro-inﬂammatory cytokines and subsequent shock by proteolytic cleavage of MAPKK. Variable number
tandem repeats (VNTRs) spread throughout the whole genome are used as molecular epidemiological markers. Abbreviations: CAP, capsule; PA, protective antigen; EF,
oedema factor; LF, lethal factor; VNTR, variable number tandem repeat; MAPKK, mitogen-activated protein kinase kinase; CaM, calmodulin; cAMP, cyclic adenosine 30 ,50-
mono phosphate.
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of virulence (Mock and Fouet, 2001). While pXO1 and pXO2 are
generally found in strains with a characteristic B. anthracis
chromosomal background, researchers have recently isolated B.
anthracis-like strains in West Africa (Ivory Coast and Cameroon)
from anthrax-like cases in great apes (Klee et al., 2006). The
sequence of the complete genome of one of these strains from the
Ivory Coast showed chromosomal properties of B. cereus but the
presence of the two virulence plasmids speciﬁc to B. anthracis
(Klee et al., 2010). The authors of this report suggested naming
these strains B. cereus variety anthracis. This type of strain seems
to be broadly spread in this geographic area, revealing the
complexity of B. anthracis taxonomy (Pilo, unpublished observa-
tions).
4. B. anthracis strain typing and molecular epidemiology
Because of the characteristic slow evolutionary change of B.
anthracis, largely determined by an alternating life cycle contain-
ing short replication phases and long sporulation periods,
common methods for strain sub-typing such as serotyping,
pulsed ﬁeld gel electrophoresis (PFGE) and multilocus sequence
typing (MLST) have insufﬁcient discriminatory power to resolvestrains of various origins (Harrell et al., 1995; Keim et al., 1997;
Helgason et al., 2004; Kim et al., 2005). Variable number tandem
repeats (VNTR) (van Belkum et al., 1998) have been found in these
species in open reading frames of genes with unknown functions
and in intergenic areas on the chromosome as well as on both
plasmids pXO1 and pXO2. VNTRs showed a mutation rate of
approximately 105–104, resulting in sufﬁcient copy number
variation to produce length polymorphisms with satisfactory
discriminatory capacity to type individual B. anthracis strains by
multiple locus VNTR analysis (MLVA) (Keim et al., 2000). Using
eight VNTRs (MLVA8), it was possible to classify 426 strains from
diverse geographical locations into 89 MLVA genotypes that
grouped into two clades (A and B) and 8 clusters (Keim et al.,
2000). This VNTR typing scheme has been widely used to examine
the diversity of B. anthracis strains from national strain collections
and has allowed examination of strains from France (Fouet et al.,
2002), Italy (Fasanella et al., 2005), Poland (Gierczynski et al.,
2004), South Africa (Smith et al., 2000), Korea (Ryu et al., 2005),
Western and Central Africa (Maho et al., 2006; Pilo, unpublished
data), Switzerland (Pilo et al., 2008), China (Simonson et al., 2009),
Bulgaria (Antwerpen et al., 2011) and Kazakhstan (Aikembayev
et al., 2010). Subsequent extension of the MLVA analysis to 15
different marker loci (MLVA15) (Van Ert et al., 2007a) and to 25
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particularly strong resolution of the more recent population level
structure of B. anthracis species. These studies suggested a relatively
recent worldwide diffusion of strains belonging to clade A (Van Ert
et al., 2007a), with the exception of subclade Ab which, from the
current information, appears to contain only strains from Chad
(Maho et al., 2006) and from other Western and Central African
countries (P. Pilo, unpublished data; Lista et al., 2006). All currently
known strains of subclade Ab lack anthrose, a speciﬁc sugar of B.
anthracis spores (Tamborrini et al., 2011). It has to be noted that
clade ‘‘E’’, as designated by Lista et al. (2006), is identical to subclade
Ab (Maho et al., 2006) (Fig. 2). The particularly wide spread of clade
A, with the exception of the subclade Ab, should be considered not
only with regard to bacterial aspects such as genetic ﬁtness,
virulence and host adaptation capacity but also from the point of
view of global trade and movement. Hence, it has been shown that
strains belonging to subcluster A4 that are spread globally can be
correlated, in many cases, with human anthrax due to contaminated
raw cashmere wool that was processed in wool factories in many
parts of the world (Pilo et al., 2008; Wattiau et al., 2008). This
explains the high occurrence and wide distribution, particularly in
Europe, of subcluster A4 and speciﬁcally A.Br008/009 as noted by
Van Ert et al. (2007a) (Fig. 2). Therefore, it is important for
epidemiological studies to distinguish between strains isolated from
bovines and strains isolated from humans. Humans may become
infected by animal products originating from sites that are often
several thousands of miles away, such as wool imported for
processing or drum skins (Pilo et al., 2008; Wattiau et al., 2008;
Anaraki et al., 2008).A
B
Aβ
Aα
C
13‘000-
26‘000 ybp
9‘000-17‘000 
ybp
3‘000-6‘000 
ybp
MLVA cclades
Fig. 2. Schematic tree summarizing the hierarchical analysis of B. anthracis populations (a
with their estimated historical split. Major subclusters (Aa1, Aa2, Aa3, Aa4, Ab, B1, B2
separately. The A radiation is indicated by a dashed rectangle.5. Global genetic population structure
While MLVA has ideal resolving power for most epidemiologi-
cal studies, single nucleotide polymorphism (SNP) analysis shows
signiﬁcantly less discrimination ability because of the slower
evolution of these markers. However, this method deﬁnes major
clonal lineages at the level of population structure, particularly for
slow-evolving organisms such as B. anthracis (Keim et al., 2004;
Van Ert et al., 2007b). Whole genome sequencing data from ﬁve
strains of B. anthracis revealed approximately 3500 SNPs, of which
about 900 could be mapped in 27 different strains and were shown
to be highly robust for the design of a phylogenetic model for B.
anthracis (Pearson et al., 2004). Out of these SNPs, a few canonical
single polymorphisms (canSNPs) were chosen to evaluate key
phylogenetic junctions to fully identify the entire genome (Van Ert
et al., 2007a). The 12 slowly evolving canSNPs have an estimated
mutation rate of about 1010. This analysis deﬁned the three
previously recognised major genetic lineages (clades A, B and C)
and further described 12 distinct sublineages (Van Ert et al., 2007a)
(Fig. 2). After coupling the MLVA15 (approximate mutation rate of
VNTRs 105) to the canSNP data set in a hierarchical manner a
progressive hierarchical resolving assay (PHRANA) was developed.
This assay allowed analysis of a collection of 1033 B. anthracis
strains from all over the world and resulted in 12 distinguished
sublineages (clusters) resolved into 221 MLVA15 genotypes. Most
of these genotypes belong to clade A (Van Ert et al., 2007a) (Fig. 2).
Van Ert et al. developed an attractive mathematical model that
allows the estimation of the divergence of the major branches of
evolution of B. anthracis. This model is based on the mutation rateA1
A2
A3
A4
B1
B2
A
-r
ad
ia
tio
n 
C.Br.A1055
B.Br.CNEVA
B.Br.001/002 (Kruger B)
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A.Br.001/002
A.Br.Ames
A.Br.003/004
WNA; A.Br.
TEA; A.Br.008/009
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C
dapted from the references cited in this review). MLVA clusters A, B and C are shown
 and C) are represented by triangles. The SNP lineages and sublineages are shown
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mous SNPs from the completely sequenced B. anthracis genomes
(Vogler et al., 2002). This is based on an ungulate transmission
model with an estimated infection/death/year rate of 1 or 0.5. This
model suggests that clade C separates approximately 13,000–
26,000 years from the lineage containing clades A and B. In
addition, clade A separated from clade B about 9000–17,000 years
ago (Van Ert et al., 2007a) (Fig. 2). Furthermore, the authors of this
study estimated the radiation of clade A into a large number of
clusters to have occurred in the mid-Holocene, about 3000–6000
years ago (Van Ert et al., 2007a), probably due to domestication of
small and large ruminants and human migration events. It should
be noted that the estimated infection/death/year rate has since
been reduced to 0.28 generations per year. This reduction was
based on an overview of anthrax outbreaks in cattle in Northern
Canada that identiﬁed 13 outbreaks in 46 years (1962–1991)
(Dragon and Elkin, 2001), which would indicate that the radiation
of clade A occurred about 10,000 years ago (Keneﬁc et al., 2009).
6. Geographical spread of B. anthracis clusters and sublineages
Analysis of the dispersal of B. anthracis around the world must
take into account human and animal products, such as goat and
sheep hair for wool production, human and animal movements
and transport of primary hosts carrying the pathogen. However,
many samples stored in regional, national and international strain
collections rarely contain detailed data on the epidemiological
background of the infection or environmental information
regarding the isolation of the strains. B. anthracis represents a
model organism to track ancient epidemiological events due its
strictly clonal reproductive mode and the low frequency of
polymorphisms in its evolutionary molecular markers. Using a
large genetic data set from an extensive strain collection and
focusing on strains from wild and domestic animals, Keim’s group
was able to demonstrate that the most drastic clonal expansion of
B. anthracis was the spread of clade A that was tracked back to the
Eurasian area where the lineage ‘Western North America’ (WNA)
split from the ‘Trans-Eurasian’ lineage (TEA, A.Br.008/009),
represented in cluster A1 (Fig. 2), and was introduced to North
America in the pre-Columbian era (Keneﬁc et al., 2009). The
evolutionary period during which the WNA lineage divided from
the TEA ancestor was estimated by SNP analysis to be the late
Pleistocene epoch (Keneﬁc et al., 2009). Strains from the WNA
lineage were predominantly isolated between the near Arctic circle
in Canada and the US-Mexican border from animal anthrax cases
and could be shown by SNP analysis to have evolved into six sub-
lineages during the epidemic spread of anthrax from the extreme
north to the south of the North American sub-continent (Keneﬁc
et al., 2009). This study represents one of the most extensive
bacterial phylogeographical surveys encompassing this long time
period. In contrast to this study of ‘‘natural’’ spread of B. anthracis,
previous analyses indicated a very scattered spread inﬂuenced by
rapid transport of B. anthracis, for example by contaminated animal
products such as hair, over long distances (Van Ert et al., 2007a).
Hence, it has been shown that the broad worldwide spread of
cluster A4 (A.Br.Vollum) is likely due to the intensive processing of
cashmere wool in many European countries and on other
continents during early industrialisation. Strains of cluster A4
can indeed be traced back to cases of human anthrax in wool
factory workers, indicating that the origin of this lineage may be
the northern part of the Indian sub-continent (Pilo et al., 2008;
Wattiau et al., 2008). Similar parameters likely also contributed to
the worldwide spread of cluster A3 (A.Br.Ames, A.Br.003/004)
(Simonson et al., 2009), while B.Br.CNEVA is thought to represent a
newer European lineage of cattle-infecting strains (Fouet et al.,
2002; Van Ert et al., 2007a; Pilo et al., 2008).7. Pathogenic evolution
The pathogenic evolution of B. anthracis should be examined in
comparison to the B. cereus group of bacteria, which comprises
mostly soil-dwelling saprophytes and also certain animal and
human pathogens causing food poisoning, systemic infections and
anthrax. The two virulence plasmids pXO1 and pXO2 (Okinaka
et al., 1999) play a central role in the virulence of B. anthracis.
Strains that have been cured of one plasmid are non-virulent (in
case of pXO1) or highly attenuated (in case of pXO2) and can serve
as live vaccines like the strain ‘Sterne’ (Sterne, 1988). Hence, the
presence of pXO1 and pXO2 is key for the determination of
clinically relevant strains of B. anthracis (WHO, 1998). It is
hypothesised that B. anthracis derived from a B. cereus common
ancestor by acquiring plasmids and various chromosomal muta-
tions (Slamti et al., 2004; Okinaka et al., 2006; Ross et al., 2009). As
replication of B. anthracis is mainly restricted to the infectious
cycles within the host, survival of this bacterial species selects
highly for the presence of both plasmids, which are consequently
an intrinsic part of this species and must have contributed to the
formation of this species. It is important to note that the two highly
pathogenic members of the B. cereus group, B. anthracis and emetic
B. cereus, both belong to the B. cereus clade 1 (Didelot et al., 2009;
Hu et al., 2009). This clonal relationship may be due to the capacity
of this cluster to support pXO1-like repX replicons that carry, in the
case of B. anthracis, the genes specifying lethal toxin and oedema
factor, and in case of emetic B. cereus, the emetic toxin cereulide
synthetase genes, while pXO2-like plasmids can be transferred
between the three clades of the B. cereus group (Hu et al., 2009).
Therefore, pXO1 and pXO2 do not seem to be limited to B. anthracis.
Plasmids similar to pXO1 and pXO2 have been found in related
Bacillus species (Pannucci et al., 2002a,b; Hoffmaster et al., 2004;
Hu et al., 2009). Anthrax-like cases in primates caused by an agent
with phenotypic and chromosomal characteristics of B. cereus but
containing plasmids pXO1 and pXO2 are of particular interest and
have recently been analysed in detail (Klee et al., 2006, 2010).
Although such strains are rarely encountered, our recent unpub-
lished results reveal that they can also be isolated from bovines
that have succumbed to anthrax in Western Africa.
At a chromosomal level, species belonging to the B. cereus group
are closely related (Ivanova et al., 2003). Only relatively small
differences in the chromosome account for the distinctive
phenotypic differences between B. cereus and B. anthracis, for
example variations in the gamR gene encoding the g-phage
receptor in B. anthracis, variations in the regulator plcR gene, or
diversity in the anti-sigma factor responsible for the expression of
the beta-lactamase genes bla1 and bla2 in B. cereus and the
repression of bla1 and bla2 in B. anthracis rendering it penicillin-
susceptible (Agaisse et al., 1999; Chen et al., 2003; Slamti et al.,
2004; Davison et al., 2005; Gohar et al., 2008; Ross et al., 2009).
This indicates that the identity of the different species at the
chromosomal level is mainly due to differential gene expression or
a small set of genes rather than to vast rearrangements in the
genome (Read et al., 2003; Ivanova et al., 2003).
8. Conclusions
Because of its life cycle that has a very low multiplication rate of
0.28–1 generation per year, B. anthracis is a highly homogeneous
species and can be considered to be relatively monomorphic. This
characteristic makes B. anthracis an ideal organism to study
vertical evolution over extended periods of time. The use of highly
stable phylogenetic markers, SNPs, has proven to be useful in
identifying extended branches and key phylogenetic positions in
long-term evolutionary studies, while more variable VNTR loci
allow detailed subtyping of the major clades into clusters and
P. Pilo, J. Frey / Infection, Genetics and Evolution 11 (2011) 1218–1224 1223subclusters. This detailed subtyping allowed the discrimination of
more recent events in the evolution of B. anthracis and is useful for
molecular epidemiological studies. Higher resolution analysis can
be performed using single nucleotide repeats (SNRs) markers that
have a mutation rate in the range of 104–103 for speciﬁc
outbreaks or forensic investigations (Keim et al., 2004). Virulence is
an intrinsic characteristic of B. anthracis and is vital for its survival.
Therefore, it is hypothesised that the acquisition of the two
virulence plasmids occurred at the genesis of this species and that
these plasmids have been retained until the present time. These
plasmids can also be found, sometimes with modiﬁcation, in
related Bacillus species, resulting in highly virulent anthrax-
causing strains. From a phylogenetic and taxonomic point of view,
it is debatable whether such strains belong to the B. anthracis or B.
cereus species; however, it seems from a medical perspective
coherent to designate closely related agents that cause symptoms
of anthrax with the same species name.
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